Clinical Trial Update: A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced Subjects [Phase 2]

View source ↗

Summary

Phase 2 safety and efficacy study of amdoxovir in HIV-1 treatment-experienced subjects was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Amdoxovir (amdoxovir)

Snippet

Sponsor: RFS Pharma, LLC | Conditions: Human Immunodeficiency Virus Infection | Phase 2 | Status: WITHDRAWN